Furthermore, it is reported that DMT1 was colocalized with Aβ in the plaques of postmortem AD brain and the levels of DMT1 was significantly increased in the cortex and hippocampus in APP/PS1 transgenic mouse model compared with wild type-control (Zheng et al., 2009). The gene discussed is APP; the disease is Alzheimer disease.